Fear recognition deficits after focal brain damage: a cautionary note.

Objective: To test the hypothesis that fear recognition deficits in neurologic patients reflect damage to an emotion-specific neural network. Background: Previous studies have suggested that the perception of fear in facial expressions is mediated by a specialized neural system that includes the amygdala and certain posterior right-hemisphere cortical regions. However, the neuropsychological findings in patients with amygdala damage are inconclusive, and the contribution of distinct cortical regions to fear perception has only been examined in one study. Methods: We studied the recognition of six basic facial expressions by asking subjects to match these emotions with the appropriate verbal labels. Results: Both normal control subjects (n = 80) and patients with focal brain damage (n = 63) performed significantly worse in recognizing fear than in recognizing any other facial emotion, with errors consisting primarily of mistaking fear for surprise. Although patients were impaired relative to control subjects in recognizing fear, we could not obtain convincing evidence that left, right, or bilateral lesions were associated with disproportionate impairments of fear perception once we adjusted for differences in overall recognition performance for the other five facial emotion categories. The proposed special role of the amygdala and posterior right-hemisphere cortical regions in fear perception was also not supported. Conclusions: Fear recognition deficits in neurologic patients may be attributable to task difficulty factors rather than damage to putative neural systems dedicated to fear perception.

[1]  N. Delanty,et al.  Risk of Alzheimer's disease and duration of NSAID use , 1998, Neurology.

[2]  Šimon Scharf,et al.  A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease , 1999, Neurology.

[3]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[4]  D. Neary Lesion Analysis in Neuropsychology , 1990 .

[5]  L. Friberg,et al.  Studies on similarity diagnosis in twins with the aid of mailed questionnaires. , 1961, Acta genetica et statistica medica.

[6]  A. Hofman,et al.  Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? , 1995, Neurology.

[7]  Marjorie Nicholas,et al.  The expression and perception of facial emotion in brain-damaged patients , 1986, Neuropsychologia.

[8]  S. Rauch,et al.  Masked Presentations of Emotional Facial Expressions Modulate Amygdala Activity without Explicit Knowledge , 1998, The Journal of Neuroscience.

[9]  Y. Agid,et al.  Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease. , 1998, Archives of neurology.

[10]  Charles L. Wilson,et al.  Single Neuron Activity in Human Hippocampus and Amygdala during Recognition of Faces and Objects , 1997, Neuron.

[11]  D. Jeste,et al.  Diagnostic validity of the dementia questionnaire for Alzheimer disease. , 1998, Archives of neurology.

[12]  P. S. St George-Hyslop,et al.  Alzheimer's disease , 1996, Neurology.

[13]  A K Anderson,et al.  Intact recognition of vocal expressions of fear following bilateral lesions of the human amygdala. , 1998, Neuroreport.

[14]  D. Amaral,et al.  The three-dimensional organization of the hippocampal formation: A review of anatomical data , 1989, Neuroscience.

[15]  P. Mcgeer,et al.  Immune System Response in Alzheimer's Disease , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[16]  P. Ekman Pictures of Facial Affect , 1976 .

[17]  M. Folstein,et al.  Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. , 1995, Archives of neurology.

[18]  G. V. Van Hoesen,et al.  Perforant pathway changes and the memory impairment of Alzheimer's disease , 1986, Annals of neurology.

[19]  Karl J. Friston,et al.  A neuromodulatory role for the human amygdala in processing emotional facial expressions. , 1998, Brain : a journal of neurology.

[20]  P. Aisen,et al.  Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain , 1998, Neuroscience.

[21]  K. Davis,et al.  Inflammatory mechanisms in Alzheimer's disease: implications for therapy. , 1994, The American journal of psychiatry.

[22]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[23]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions , 1995, Journal of neural transmission. Parkinson's disease and dementia section.

[24]  D. Perrett,et al.  A differential neural response in the human amygdala to fearful and happy facial expressions , 1996, Nature.

[25]  I. McKeith,et al.  HLA‐DR antigens associated with major genetic risk for late‐onset Alzheimer's disease , 1997, Neuroreport.

[26]  D. Perrett,et al.  A specific neural substrate for perceiving facial expressions of disgust , 1997, Nature.

[27]  A. Convit,et al.  Cortisol levels during human aging predict hippocampal atrophy and memory deficits , 1998, Nature Neuroscience.

[28]  E. Rolls,et al.  Neurons in the amygdala of the monkey with responses selective for faces , 1985, Behavioural Brain Research.

[29]  Steven M. Horvath,et al.  Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.

[30]  S. Tomkins,et al.  What and Where are the Primary Affects? Some Evidence for a Theory , 1964, Perceptual and motor skills.

[31]  S. Rauch,et al.  Response and Habituation of the Human Amygdala during Visual Processing of Facial Expression , 1996, Neuron.

[32]  Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. , 1986, The American journal of psychiatry.

[33]  E. Peskind,et al.  Effect of Chronic High-Dose Exogenous Cortisol on Hippocampal Neuronal Number in Aged Nonhuman Primates , 1999, The Journal of Neuroscience.

[34]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[35]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[36]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[37]  M. Pericak-Vance,et al.  Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs , 1995, Neurobiology of Aging.

[38]  M. Mandal,et al.  Right Brain Damage Impairs Recognition of Negative Emotions , 1991, Cortex.

[39]  E. Tangalos,et al.  Mayo Clinic Alzheimer’s Disease Patient Registry , 1990, Aging.

[40]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[41]  W. McDonald,et al.  Inverse association of anti‐inflammatory treatments and Alzheimer's disease , 1994, Neurology.

[42]  J. Overall,et al.  The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. , 1984, Journal of gerontology.

[43]  P. Aisen,et al.  Glucocorticoids in Alzheimer's disease. The story so far. , 1998, Drugs & aging.

[44]  K. Davis,et al.  A pilot study of prednisone in Alzheimer's disease. , 1996, Dementia.

[45]  J. Breitner,et al.  Detection of dementia in the elderly using telephone screening of cognitive status , 1993 .

[46]  J. Haines,et al.  Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. , 1997, JAMA.

[47]  J. Greene Contributions to Neuropsychological Assessment , 1995 .

[48]  Barry Horwitz,et al.  Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type , 1995, Psychiatry Research.

[49]  P. Worley,et al.  Cyclooxygenases and the central nervous system. , 1997, Prostaglandins.

[50]  K. Pettigrew,et al.  Discordance and concordance of dementia of the Alzheimer type (DAT) in monozygotic twins indicate heritable and sporadic forms of Alzheimer's disease , 1991, Neurology.

[51]  L. Mucke,et al.  Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. , 1997, Brain research. Brain research reviews.

[52]  P. Broks,et al.  Face processing impairments after encephalitis: amygdala damage and recognition of fear , 2000 .

[53]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[54]  E G Tangalos,et al.  Memory function in very early Alzheimer's disease , 1994, Neurology.

[55]  R. Adolphs,et al.  Fear and the human amygdala , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[56]  R. Adolphs,et al.  Cortical Systems for the Recognition of Emotion in Facial Expressions , 1996, The Journal of Neuroscience.

[57]  J. Kaye,et al.  Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia , 1997, Neurology.

[58]  N Butters,et al.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. , 1991, Archives of neurology.

[59]  M. Folstein,et al.  Nonsteroidal anti-inflammatory drugs in Alzheimer's disease , 1995, Neurology.

[60]  H. Soininen,et al.  Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age‐associated memory impairment , 1994, Neurology.

[61]  L. Squire Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. , 1992, Psychological review.

[62]  R. Adolphs,et al.  Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala , 1994, Nature.

[63]  J. Russell Is there universal recognition of emotion from facial expression? A review of the cross-cultural studies. , 1994, Psychological bulletin.

[64]  A. Kaszniak,et al.  Clinical trial of indomethacin in Alzheimer's disease , 1993, Neurology.

[65]  G. V. Hoesen,et al.  The parahippocampal gyrus: New observations regarding its cortical connections in the monkey , 1982, Trends in Neurosciences.

[66]  D. Carmelli,et al.  Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. , 1994, Archives of neurology.

[67]  P. S. St George-Hyslop,et al.  Monozygotic twins concordant for late-onset probable Alzheimer disease with suspected Alzheimer disease in four sibs. , 1992, American journal of medical genetics.

[68]  Gwenn S. Smith,et al.  EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS , 1989, The Lancet.

[69]  B Horwitz,et al.  Critical analysis of the use of computer‐assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type , 1990, Neurology.

[70]  Douglas L. Rosene,et al.  The Hippocampal Formation of the Primate Brain , 1987 .

[71]  Peter Brugger,et al.  A comparison of category and letter fluency in Alzheimer's disease and Huntington's disease. , 1994 .

[72]  Hanna Damasio,et al.  Recognizing facial emotion , 1996, Nature.

[73]  P. Ekman,et al.  Matsumoto and Ekman's Japanese and Caucasian Facial Expressions of Emotion (JACFEE): Reliability Data and Cross-National Differences , 1997 .

[74]  M. Tuszynski,et al.  A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease , 1996, Neurology.

[75]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[76]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[77]  M J de Leon,et al.  Hippocampal formation size predicts declining memory performance in normal aging , 1996, Neurology.

[78]  E. Kaplan,et al.  The Boston naming test , 2001 .

[79]  E. Tangalos,et al.  Memory function in normal aging , 1992, Neurology.

[80]  P. Aisen,et al.  HLA-DR4 influences glial activity in Alzheimer's disease hippocampus , 1998, Journal of the Neurological Sciences.

[81]  E. Smeraldi,et al.  Serum cholinesterase in obsessive-compulsive disorder , 1995, Psychiatry Research.

[82]  G. V. Van Hoesen Neural systems of the non-human primate forebrain implicated in memory. , 1985, Annals of the New York Academy of Sciences.

[83]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[84]  Nick C Fox,et al.  Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. , 1996, Brain : a journal of neurology.

[85]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[86]  R. Gur,et al.  Mood effects on limbic blood flow correlate with emotional self-rating: A PET study with oxygen-15 labeled water , 1995, Psychiatry Research: Neuroimaging.

[87]  N Butters,et al.  Cortical Afferents to the Entorhinal Cortex of the Rhesus Monkey , 1972, Science.

[88]  J C Mazziotta,et al.  Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. , 1995, JAMA.

[89]  M. Sonnenblick,et al.  Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. , 1994, The Journal of rheumatology.

[90]  Wolfgang Grodd,et al.  Functional MRI reveals left amygdala activation during emotion , 1997, Psychiatry Research: Neuroimaging.

[91]  S. Torgersen The determination of twin zygosity by means of a mailed questionnaire. , 1979, Acta geneticae medicae et gemellologiae.

[92]  J. Kaye,et al.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. , 1997, American journal of human genetics.

[93]  D. Perrett,et al.  Dissociable neural responses to facial expressions of sadness and anger. , 1999, Brain : a journal of neurology.

[94]  A. Calder Facial Emotion Recognition after Bilateral Amygdala Damage: Differentially Severe Impairment of Fear , 1996 .

[95]  B. McEwen,et al.  Re-examination of the glucocorticoid hypothesis of stress and aging. , 1992, Progress in brain research.

[96]  PhilipR. Wenham,et al.  Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.

[97]  S Lehéricy,et al.  Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[98]  P. Aisen,et al.  Regional distribution of cyclooxygenase‐2 in the hippocampal formation in Alzheimer's disease , 1999, Journal of neuroscience research.

[99]  P. Ekman Emotion in the human face , 1982 .

[100]  C. Derouesné [Mini-mental state examination]. , 2001, Revue neurologique.

[101]  M. Folstein,et al.  Diagnosis of Alzheimer's disease in epidemiologic studies by staged review of clinical data , 1996 .

[102]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[103]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.